Company · CIK 0001124105 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
GYRE THERAPEUTICS, INC. · GYRE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 SForm 4 → | Jun 15, 4:01 pm EDT | Weiguo YeChief Operating Officer | 2,800 | $6.17 | $17,276 | 700,000 | −0.40% | |
| Jun 11, 2026 MForm 4 → | Jun 15, 4:01 pm EDT | Weiguo YeChief Operating Officer | 2,800 | $0.75 | $2,100 | 702,800 | — | |
| Jun 9, 2026 SForm 4 → | Jun 22, 4:02 pm EDT | Weiguo YeChief Operating Officer | 11,000 | $6.25 | $68,700 | 700,000 | −1.55% | late |
| Jun 9, 2026 MForm 4 → | Jun 22, 4:02 pm EDT | Weiguo YeChief Operating Officer | 11,000 | $0.75 | $8,250 | 703,000 | — | late |
| Jun 9, 2026 SForm 4 → | Jun 11, 4:01 pm EDT | Weiguo YeChief Operating Officer | 20,918 | $6.16 | $128,886 | 700,000 | −2.90% | |
| Jun 9, 2026 MForm 4 → | Jun 11, 4:01 pm EDT | Weiguo YeChief Operating Officer | 20,918 | $0.75 | $15,689 | 706,418 | — | |
| Jun 4, 2026 SForm 4 → | Jun 8, 4:01 pm EDT | Weiguo YeChief Operating Officer | 34,976 | $6.25 | $218,561 | 700,000 | −4.76% | |
| Jun 4, 2026 MForm 4 → | Jun 8, 4:01 pm EDT | Weiguo YeChief Operating Officer | 34,976 | $0.75 | $26,232 | 715,401 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 AForm 4 → | Aug 4, 8:45 pm EDT | Claire WestonDirector | 40,000 | — | — | 40,000 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 8:39 pm EDT | Maxwell KirkbyDirector | 40,000 | — | — | 40,000 | — | |
| Jun 11, 2026 MForm 4 → | Jun 15, 4:01 pm EDT | Weiguo YeChief Operating Officer | 2,800 | — | — | 838,701 | — | |
| Jun 10, 2026 AForm 4 → | Jun 30, 6:17 pm EDT | Gordon CarmichaelDirector | 40,000 | — | — | 40,000 | — | late |
| Jun 10, 2026 AForm 4 → | Jun 30, 6:17 pm EDT | David M. EpsteinDirector | 40,000 | — | — | 40,000 | — | late |
| Jun 10, 2026 AForm 4 → | Jun 30, 6:17 pm EDT | Dan WengDirector | 40,000 | — | — | 40,000 | — | late |
| Jun 10, 2026 AForm 4 → | Jun 30, 6:17 pm EDT | Renate ParryDirector | 40,000 | — | — | 40,000 | — | late |
| Jun 10, 2026 AForm 4 → | Jun 30, 6:17 pm EDT | Ping ZhangDirector | 40,000 | — | — | 40,000 | — | late |
| Jun 10, 2026 AForm 4 → | Jun 30, 6:17 pm EDT | Rodney L NussbaumDirector | 40,000 | — | — | 40,000 | — | late |
| Jun 9, 2026 MForm 4 → | Jun 22, 4:02 pm EDT | Weiguo YeChief Operating Officer | 11,000 | — | — | 827,701 | — | late |
| Jun 9, 2026 MForm 4 → | Jun 11, 4:01 pm EDT | Weiguo YeChief Operating Officer | 20,918 | — | — | 841,501 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 4:13 pm EDT | Joshua Benjamin BergmannGC and Corporate Secretary | 50,000 | — | — | 50,000 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 4:13 pm EDT | Ying LuoChief Executive Officer, Director | 120,000 | — | — | 120,000 | — | |
| Jun 4, 2026 MForm 4 → | Jun 8, 4:01 pm EDT | Weiguo YeChief Operating Officer | 34,976 | — | — | 862,419 | — |